Showing results (361-370 of 408) with videos related to
Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2019
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12Emmanouil Fokas, Michael Allgäuer, Bülent Polat, et al.Trials|August 20, 2025
Randomized adaptive assessment of post COVID syndrome treatments (RAPID): a study protocol for a multicenter, randomized, controlled adaptive platform trial of treatment options for Post Covid Syndrome (PCS) on patients physical function including the first intervention specific appendix RAPID_REVIVE (reducing inflammatory activity in patients with PCS)Lisa Weipert, Ralph G Telgmann, Gabriele Anton, et al.Journal of Cachexia, Sarcopenia and Muscle|March 13, 2026
Evaluation of Dysphagia in Myositis and Muscular Dystrophy Using Real-Time MRI and Quantitative Muscle UltrasoundRachel Zeng, Anke Rietveld, Omar Al-Bourini, et al.European Journal of Heart Failure|March 14, 2026
Effects of Sauna bathing on Exercise Capacity and Muscle Function in HFpEFTarek Bekfani, Ammar Abo Hwach, Ricarda Moebert, et al.JAMA Oncology|November 18, 2021
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical TrialEmmanouil Fokas, Anke Schlenska-Lange, Bülent Polat, et al.Multiple Sclerosis and Related Disorders|November 24, 2023
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.Journal of Cachexia, Sarcopenia and Muscle|May 24, 2023
Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancerMarkus S Anker, Alessia Lena, Eric J Roeland, et al.Kidney International|December 15, 2011
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancyOliver Gross, Christoph Licht, Hans J Anders, et al.Kidney International Reports|December 19, 2024
SGLT2-Inhibition in Patients With Alport SyndromeJan Boeckhaus, Daniel P Gale, James Simon, et al.The New England Journal of Medicine|March 18, 2026
Left Atrial Appendage Closure or Medical Therapy in Atrial FibrillationUlf Landmesser, Carsten Skurk, Paulus Kirchhof, et al.Pageof 41